<author><surname>Macmillan</surname> <given-names>AK</given-names> </author><author><surname>Merrie</surname> <given-names>AE</given-names> </author><author><surname>Marshall</surname> <given-names>RJ</given-names> </author><author><surname>Parry</surname> <given-names>BR</given-names> </author><title>The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature</title><source>Dis Colon Rectum</source><year>2004</year><volume>47</volume><fpage>1341</fpage><lpage>1349</lpage>
<author><surname>Shafik</surname> <given-names>A</given-names> </author><title>Polytetrafluoroethylene injection for the treatment of partial fecal incontinence</title><source>Int Surg</source><year>1993</year><volume>78</volume><fpage>159</fpage><lpage>161</lpage>
<author><surname>Kumar</surname> <given-names>D</given-names> </author><author><surname>Benson</surname> <given-names>MJ</given-names> </author><author><surname>Bland</surname> <given-names>JE</given-names> </author><title>Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence</title><source>Br J Surg</source><year>1998</year><volume>85</volume><fpage>978</fpage><lpage>979</lpage>
<author><surname>Shafik</surname> <given-names>A</given-names> </author><title>Perianal injection of autologous fat for treatment of sphincteric incontinence</title><source>Dis Colon Rectum</source><year>1995</year><volume>38</volume><fpage>583</fpage><lpage>587</lpage>
<author><surname>Malouf</surname> <given-names>AJ</given-names> </author><author><surname>Vaizey</surname> <given-names>CJ</given-names> </author><author><surname>Norton</surname> <given-names>CS</given-names> </author><author><surname>Kamm</surname> <given-names>MA</given-names> </author><title>Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial</title><source>Dis Colon Rectum</source><year>2001</year><volume>44</volume><fpage>595</fpage><lpage>600</lpage>
<author><surname>Chan</surname> <given-names>MK</given-names> </author><author><surname>Tjandra</surname> <given-names>JJ</given-names> </author><title>Injectable silicone biomaterial (PTQ) to treat fecal incontinence after hemorrhoidectomy</title><source>Dis Colon Rectum</source><year>2006</year><volume>49</volume><fpage>433</fpage><lpage>439</lpage>
<author><surname>Tjandra</surname> <given-names>JJ</given-names> </author><author><surname>Lim</surname> <given-names>JF</given-names> </author><author><surname>Hiscock</surname> <given-names>R</given-names> </author><author><surname>Rajendra</surname> <given-names>P</given-names> </author><title>Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective</title><source>Dis Colon Rectum</source><year>2004</year><volume>47</volume><fpage>2138</fpage><lpage>2146</lpage>
<author><surname>Kenefick</surname> <given-names>NJ</given-names> </author><author><surname>Vaizey</surname> <given-names>CJ</given-names> </author><author><surname>Malouf</surname> <given-names>AJ</given-names> </author><author><surname>Norton</surname> <given-names>CS</given-names> </author><author><surname>Marshall</surname> <given-names>M</given-names> </author><author><surname>Kamm</surname> <given-names>MA</given-names> </author><title>Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction</title><source>Gut</source><year>2002</year><volume>51</volume><fpage>225</fpage><lpage>228</lpage>
<author><surname>Davis</surname> <given-names>K</given-names> </author><author><surname>Kumar</surname> <given-names>D</given-names> </author><author><surname>Poloniecki</surname> <given-names>J</given-names> </author><title>Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence</title><source>Aliment Pharmacol Ther</source><year>2003</year><volume>18</volume><fpage>237</fpage><lpage>243</lpage>
<author><surname>Pannek</surname> <given-names>J</given-names> </author><author><surname>Brands</surname> <given-names>FH</given-names> </author><author><surname>Senge</surname> <given-names>T</given-names> </author><title>Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence</title><source>J Urol</source><year>2001</year><volume>166</volume><fpage>1350</fpage><lpage>1353</lpage>
<author><surname>Emans</surname> <given-names>PJ</given-names> </author><author><surname>Saralidze</surname> <given-names>K</given-names> </author><author><surname>Knetsch</surname> <given-names>ML</given-names> </author><author><surname>Gijbels</surname> <given-names>MJ</given-names> </author><author><surname>Kuijer</surname> <given-names>R</given-names> </author><author><surname>Koole</surname> <given-names>LH</given-names> </author><title>Development of new injectable bulking agents: biocompatibility of radiopaque polymeric microspheres studied in a mouse model</title><source>J Biomed Mater Res A</source><year>2005</year><volume>73</volume><fpage>430</fpage><lpage>436</lpage>
<author><surname>Kuang</surname> <given-names>S</given-names> </author><author><surname>Kuroda</surname> <given-names>K</given-names> </author><author><surname>Grand</surname> <given-names>F</given-names> </author><author><surname>Rudnicki</surname> <given-names>MA</given-names> </author><title>Asymmetric self-renewal and commitment of satellite stem cells in muscle</title><source>Cell</source><year>2007</year><volume>129</volume><fpage>999</fpage><lpage>1010</lpage>
<author><surname>Qu-Petersen</surname> <given-names>Z</given-names> </author><author><surname>Deasy</surname> <given-names>B</given-names> </author><author><surname>Jankowski</surname> <given-names>R</given-names> </author><title>Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration</title><source>J Cell Biol</source><year>2002</year><volume>157</volume><fpage>851</fpage><lpage>864</lpage>
<author><surname>Lee</surname> <given-names>JY</given-names> </author><author><surname>Paik</surname> <given-names>SY</given-names> </author><author><surname>Yuk</surname> <given-names>SH</given-names> </author><author><surname>Lee</surname> <given-names>JH</given-names> </author><author><surname>Ghil</surname> <given-names>SH</given-names> </author><author><surname>Lee</surname> <given-names>SS</given-names> </author><title>Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves</title><source>Mol Cells</source><year>2004</year><volume>18</volume><fpage>309</fpage><lpage>313</lpage>
<author><surname>Cannon</surname> <given-names>TW</given-names> </author><author><surname>Lee</surname> <given-names>JY</given-names> </author><author><surname>Somogyi</surname> <given-names>G</given-names> </author><title>Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra</title><source>Urology</source><year>2003</year><volume>62</volume><fpage>958</fpage><lpage>963</lpage>
<author><surname>Yiou</surname> <given-names>R</given-names> </author><author><surname>Yoo</surname> <given-names>JJ</given-names> </author><author><surname>Atala</surname> <given-names>A</given-names> </author><title>Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts</title><source>Transplantation</source><year>2003</year><volume>76</volume><fpage>1053</fpage><lpage>1060</lpage>
<author><surname>Kwon</surname> <given-names>D</given-names> </author><author><surname>Kim</surname> <given-names>Y</given-names> </author><author><surname>Pruchnic</surname> <given-names>R</given-names> </author><title>Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence</title><source>Urology</source><year>2006</year><volume>68</volume><fpage>449</fpage><lpage>454</lpage>
<author><surname>Lee</surname> <given-names>JY</given-names> </author><author><surname>Cannon</surname> <given-names>TW</given-names> </author><author><surname>Pruchnic</surname> <given-names>R</given-names> </author><author><surname>Fraser</surname> <given-names>MO</given-names> </author><author><surname>Huard</surname> <given-names>J</given-names> </author><author><surname>Chancellor</surname> <given-names>MB</given-names> </author><title>The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence</title><source>Int Urogynecol J Pelvic Floor Dysfunct</source><year>2003</year><volume>14</volume><fpage>31</fpage><lpage>37</lpage>
<author><surname>Yiou</surname> <given-names>R</given-names> </author><author><surname>Dreyfus</surname> <given-names>P</given-names> </author><author><surname>Chopin</surname> <given-names>DK</given-names> </author><author><surname>Abbou</surname> <given-names>CC</given-names> </author><author><surname>Lefaucheur</surname> <given-names>JP</given-names> </author><title>Muscle precursor cell autografting in a murine model of urethral sphincter injury</title><source>BJU Int</source><year>2002</year><volume>89</volume><fpage>298</fpage><lpage>302</lpage>
<author><surname>Chermansky</surname> <given-names>CJ</given-names> </author><author><surname>Tarin</surname> <given-names>T</given-names> </author><author><surname>Kwon</surname> <given-names>DD</given-names> </author><title>Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency</title><source>Urology</source><year>2004</year><volume>63</volume><fpage>780</fpage><lpage>785</lpage>
<author><surname>Strasser</surname> <given-names>H</given-names> </author><author><surname>Marksteiner</surname> <given-names>R</given-names> </author><author><surname>Margreiter</surname> <given-names>E</given-names> </author><title>Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial</title><source>Lancet</source><year>2007</year><volume>369</volume><fpage>2179</fpage><lpage>2186</lpage>
<author><surname>Garcia-Olmo</surname> <given-names>D</given-names> </author><author><surname>Garcia-Arranz</surname> <given-names>M</given-names> </author><author><surname>Garcia</surname> <given-names>LG</given-names> </author><title>Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn&#8217;s disease: a new cell-based therapy</title><source>Int J Colorectal Dis</source><year>2003</year><volume>18</volume><fpage>451</fpage><lpage>454</lpage>
<author><surname>Garcia-Olmo</surname> <given-names>D</given-names> </author><author><surname>Garcia-Arranz</surname> <given-names>M</given-names> </author><author><surname>Herreros</surname> <given-names>D</given-names> </author><author><surname>Pascual</surname> <given-names>I</given-names> </author><author><surname>Peiro</surname> <given-names>C</given-names> </author><author><surname>Rodriguez-Montes</surname> <given-names>JA</given-names> </author><title>A phase I clinical trial of the treatment of Crohn&#8217;s fistula by adipose mesenchymal stem cell transplantation</title><source>Dis Colon Rectum</source><year>2005</year><volume>48</volume><fpage>1416</fpage><lpage>1423</lpage>
<author><surname>Rando</surname> <given-names>TA</given-names> </author><author><surname>Blau</surname> <given-names>HM</given-names> </author><title>Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy</title><source>J Cell Biol</source><year>1994</year><volume>125</volume><fpage>1275</fpage><lpage>1287</lpage>
<author><surname>Huard</surname> <given-names>J</given-names> </author><author><surname>Yokoyama</surname> <given-names>T</given-names> </author><author><surname>Pruchnic</surname> <given-names>R</given-names> </author><title>Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction</title><source>Gene Ther</source><year>2002</year><volume>9</volume><fpage>1617</fpage><lpage>1626</lpage>
<author><surname>Gulbins</surname> <given-names>H</given-names> </author><author><surname>Pritisanac</surname> <given-names>A</given-names> </author><author><surname>Anderson</surname> <given-names>I</given-names> </author><title>Myoblasts for survive 16 weeks after intracardiac transfer and start differentiation</title><source>Thorac Cardiovasc Surg</source><year>2003</year><volume>51</volume><fpage>295</fpage><lpage>300</lpage>
<author><surname>Hwang</surname> <given-names>JH</given-names> </author><author><surname>Yuk</surname> <given-names>SH</given-names> </author><author><surname>Lee</surname> <given-names>JH</given-names> </author><title>Isolation of muscle derived stem cells from rat and its smooth muscle differentiation</title><source>Mol Cells</source><year>2004</year><volume>17</volume><fpage>57</fpage><lpage>61</lpage>
<author><surname>Qu</surname> <given-names>Z</given-names> </author><author><surname>Balkir</surname> <given-names>L</given-names> </author><author><surname>Deutekom</surname> <given-names>JC</given-names> </author><author><surname>Robbins</surname> <given-names>PD</given-names> </author><author><surname>Pruchnic</surname> <given-names>R</given-names> </author><author><surname>Huard</surname> <given-names>J</given-names> </author><title>Development of approaches to improve cell survival in myoblast transfer therapy</title><source>J Cell Biol</source><year>1998</year><volume>142</volume><fpage>1257</fpage><lpage>1267</lpage>
<author><surname>Beauchamp</surname> <given-names>JR</given-names> </author><author><surname>Heslop</surname> <given-names>L</given-names> </author><author><surname>Yu</surname> <given-names>DS</given-names> </author><title>Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells</title><source>J Cell Biol</source><year>2000</year><volume>151</volume><fpage>1221</fpage><lpage>1234</lpage>
<author><surname>Yokoyama</surname> <given-names>T</given-names> </author><author><surname>Huard</surname> <given-names>J</given-names> </author><author><surname>Chancellor</surname> <given-names>MB</given-names> </author><title>Myoblast therapy for stress urinary incontinence and bladder dysfunction</title><source>World J Urol</source><year>2000</year><volume>18</volume><fpage>56</fpage><lpage>61</lpage>
<author><surname>Hag&#232;ge</surname> <given-names>AA</given-names> </author><author><surname>Carrion</surname> <given-names>C</given-names> </author><author><surname>Menasch&#233;</surname> <given-names>P</given-names> </author><title>Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy</title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>491</fpage><lpage>492</lpage>
<author><surname>Alameddine</surname> <given-names>HS</given-names> </author><author><surname>Louboutin</surname> <given-names>JP</given-names> </author><author><surname>Dehaupas</surname> <given-names>M</given-names> </author><author><surname>Sebille</surname> <given-names>A</given-names> </author><author><surname>Fardeau</surname> <given-names>M</given-names> </author><title>Functional recovery induced by satellite cell grafts in irreversibly injured muscles</title><source>Cell Transplant</source><year>1994</year><volume>3</volume><fpage>3</fpage><lpage>14</lpage>
<author><surname>Guettier-Sigrist</surname> <given-names>S</given-names> </author><author><surname>Coupin</surname> <given-names>G</given-names> </author><author><surname>Warter</surname> <given-names>JM</given-names> </author><author><surname>Poindron</surname> <given-names>P</given-names> </author><title>Cell types required to efficiently innervate human muscle cells in vitro</title><source>Exp Cell Res</source><year>2000</year><volume>259</volume><fpage>204</fpage><lpage>212</lpage>
<author><surname>Alessandri</surname> <given-names>G</given-names> </author><author><surname>Pagano</surname> <given-names>S</given-names> </author><author><surname>Bez</surname> <given-names>A</given-names> </author><title>Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages</title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>1872</fpage><lpage>1883</lpage>